Innate Pharma SA Key Management Personnel Compensation Shortterm Employee Benefits
Innate Pharma SA (IPHYF) reported Key Management Personnel Compensation Shortterm Employee Benefits of EUR 3.49 million for the 12-month period ending 2025-12-31, per its 20-F filed 2026-04-01.
Financial Statements › Expense Statement › Operating Expenses
ifrs-full:KeyManagementPersonnelCompensationShorttermEmployeeBenefits · last filed 2026-04-01
| Period end | Key Management Personnel Compensation Shortterm Employee Benefits 6 month | Key Management Personnel Compensation Shortterm Employee Benefits 12 month |
|---|---|---|
| 2025-12-31 | 3.49M EUR 20-F · filed 2026-04-01 | |
| 2025-06-30 | 1.86M EUR 6-K · filed 2025-09-17 | |
| 2024-12-31 | 3.83M EUR 20-F · filed 2026-04-01 | |
| 2024-06-30 | 1.71M EUR 6-K · filed 2025-09-17 | |
| 2023-12-31 | 2.86M EUR 20-F · filed 2026-04-01 | |
| 2023-06-30 | 1.39M EUR 6-K · filed 2024-09-12 | |
| 2022-12-31 | 2.18M EUR 20-F · filed 2025-04-30 | |
| 2022-06-30 | 1.21M EUR 6-K · filed 2023-09-14 | |
| 2021-12-31 | 3.46M EUR 20-F · filed 2024-04-04 | |
| 2021-06-30 | 1.88M EUR 6-K · filed 2022-09-15 | |
| 2020-12-31 | 3.13M EUR 20-F · filed 2023-04-06 | |
| 2020-06-30 | 1.46M EUR 6-K · filed 2021-09-15 | |
| 2019-12-31 | 2.81M EUR 20-F · filed 2022-04-04 | |
| 2018-12-31 | 2.34M EUR 20-F · filed 2021-04-27 | |
| 2017-12-31 | 1.59M EUR 20-F · filed 2020-04-24 |